LEMD is found to promote proliferation in gastric cancer via activating the PI3K/Akt signaling pathway (56), and is also found to be active in tumorigenesis in colorectal cancer (57) and prostate cancer (58). This evidence concerns the gene PIK3CA and Familial prostate cancer.